Inventor · disambiguated record
Steven B. Kanner
Also filed as: KANNER STEVEN · KANNER STEVEN B · KANNER STEVEN BRIAN
44 granted patents·22 pending applications·257 citations·filing 2001–2025
98Inventor score
Files withARROWHEAD PHARMACEUTICALS INC19AGENSYS INC13BRISTOL MYERS SQUIBB CO11CARIBOU BIOSCIENCES INC5RAITANO ARTHUR B4
Top patents by PatentIndex Score
66 records- 0196US6706717B2Thiazolyl inhibitors of Tec family tyrosine kinasesBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Mar 16, 2004·73 cites·11 claims
- 0295US9932586B2Compositions and methods for inhibiting gene expression of LPAARROWHEAD PHARMACEUTICALS INC·Filed 2016·Granted Apr 3, 2018·9 cites·39 claims
- 0395US9394257B2PKM2 modulators and methods for their useTOLERO PHARMACEUTICALS INC·Filed 2013·Granted Jul 19, 2016·22 cites·52 claims
- 0495US7427399B2Antibodies and related molecules that bind to 161P2F10B proteinsAGENSYS INC·Filed 2006·Granted Sep 23, 2008·21 cites·21 claims
- 0594US12188017B2Compositions and methods for inhibiting gene expression of alpha-1 antitrypsinARROWHEAD PHARMACEUTICALS INC·Filed 2022·Granted Jan 7, 2025·1 cites·12 claims
- 0694US11214801B2RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (APOC3)ARROWHEAD PHARMACEUTICALS INC·Filed 2020·Granted Jan 4, 2022·3 cites·30 claims
- 0793US10662427B2Compositions and methods for inhibiting gene expression of LPAARROWHEAD PHARMACEUTICALS INC·Filed 2018·Granted May 26, 2020·6 cites·39 claims
- 0893US10597657B2RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (APOC3)ARROWHEAD PHARMACEUTICALS INC·Filed 2018·Granted Mar 24, 2020·6 cites·51 claims
- 0993US7811565B2Antibodies and related molecules that bind to 161P2F10B proteinsAGENSYS INC·Filed 2009·Granted Oct 12, 2010·20 cites·20 claims
- 1093US7241781B2Thiazolyl inhibitors of Tec family tyrosine kinasesBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Jul 10, 2007·17 cites·16 claims
- 1192US9803205B2Compositions and methods for inhibiting gene expression of factor XIIARROWHEAD MADISON INC·Filed 2016·Granted Oct 31, 2017·9 cites·25 claims
- 1291US11384355B2Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsinARROWHEAD PHARMACEUTICALS INC·Filed 2019·Granted Jul 12, 2022·3 cites·23 claims
- 1391US8039597B2Antibodies and related molecules that bind to 24P4C12 proteinsAGENSYS INC·Filed 2008·Granted Oct 18, 2011·11 cites·24 claims
- 1490US2025197861A1Compositions and methods for inhibiting gene expression of alpha-1 antitrypsinARROWHEAD PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1588US10006025B2Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsinARROWHEAD MADISON INC·Filed 2015·Granted Jun 26, 2018·5 cites·25 claims
- 1687US10308941B2Compositions and methods for inhibiting gene expression of factor XIIARROWHEAD PHARMACEUTICALS INC·Filed 2017·Granted Jun 4, 2019·4 cites·26 claims
- 1787US8350009B2Antibodies and related molecules that bind to 161P2F10B proteinsAGENSYS INC·Filed 2010·Granted Jan 8, 2013·6 cites·8 claims
- 1886US10927373B2Compositions and methods for inhibiting gene expression of Hif2alphaARROWHEAD PHARMACEUTICALS INC·Filed 2018·Granted Feb 23, 2021·2 cites·20 claims
- 1986US9976141B2Compositions and methods for inhibiting gene expression of Hif2alphaARROWHEAD MADISON INC·Filed 2016·Granted May 22, 2018·5 cites·32 claims
- 2086US2025115907A1Compositions and methods for inhibiting gene expression of lpaARROWHEAD PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2185US12365899B2RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (APOC3)ARROWHEAD PHARMACEUTICALS INC·Filed 2022·Granted Jul 22, 2025·0 cites·22 claims
- 2284US8236310B2Antibodies and related molecules that bind to 161P2F10B proteinsJAKOBOVITS AYA·Filed 2010·Granted Aug 7, 2012·6 cites·17 claims
- 2383US2025090584A1Treatment of autoimmune diseases with engineered immune cellsCARIBOU BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 2482US10766865B2PKM2 modulators and methods for their useTOLERO PHARMACEUTICALS INC·Filed 2019·Granted Sep 8, 2020·1 cites·17 claims
- 2582US10472328B2PKM2 modulators and methods for their useTOLERO PHARMACEUTICALS INC·Filed 2018·Granted Nov 12, 2019·2 cites·20 claims
- 2679US10207996B2PKM2 modulators and methods for their useTOLERO PHARMACEUTICALS INC·Filed 2016·Granted Feb 19, 2019·2 cites·37 claims
- 2779US7358353B2Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancersAGENSYS INC·Filed 2004·Granted Apr 15, 2008·7 cites·4 claims
- 2878US2025345424A1Treatment of autoimmune diseases with engineered immune cellsCARIBOU BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 2977US7811575B2Nucleic acids and corresponding proteins entitled 158P3D2 useful in treatment and detection of cancerAGENSYS INC·Filed 2004·Granted Oct 12, 2010·2 cites·5 claims
- 3077US2022064646A1RNAi Agents And Compositions for Inhibiting Expression of Apolipoprotein C-III (APOC3)ARROWHEAD PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3175US8945570B2Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancersAGENSYS INC·Filed 2012·Granted Feb 3, 2015·1 cites·16 claims
- 3274US11840688B2Compositions and methods for inhibiting gene expression of Hif2alphaARROWHEAD PHARMACEUTICALS INC·Filed 2021·Granted Dec 12, 2023·0 cites·20 claims
- 3374US10858658B2Compositions and methods for inhibiting gene expression of factor XIIARROWHEAD PHARMACEUTICALS INC·Filed 2019·Granted Dec 8, 2020·0 cites·19 claims
- 3473US7927597B2Methods to inhibit cell growthAGENSYS INC·Filed 2004·Granted Apr 19, 2011·1 cites·10 claims
- 3571US7101686B1Polynucleotides encoding human SLAP-2:a novel SH2/SH3 domain-containing human SLAP homologue having immune cell-specific expressionBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Sep 5, 2006·2 cites·13 claims
- 3671US2021002233A1Pkm2 modulators and methods for their useSUMITOMO DAINIPPON PHARMA ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 3769US6958336B2Thiazolyl inhibitors of Tec family tyrosine kinasesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Oct 25, 2005·2 cites·17 claims
- 3869US6956045B2Thiazolyl inhibitors of Tec family tyrosine kinasesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Oct 18, 2005·2 cites·17 claims
- 3969US6953795B2Thiazolyl inhibitors of Tec family tyrosine kinasesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Oct 11, 2005·2 cites·17 claims
- 4069US2020263179A1Compositions and methods for inhibiting gene expression of lpaARROWHEAD PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4166US8460881B2Nucleic acids and corresponding proteins entitled 254P1D6B useful in treatment and detection of cancerRAITANO ARTHUR B·Filed 2009·Granted Jun 11, 2013·0 cites·2 claims
- 4266US7037926B2Thiazolyl inhibitors of Tec family tyrosine kinasesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted May 2, 2006·1 cites·17 claims
- 4366US2009252728A1Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancersJAKOBOVITS AYA·Filed 2008·Application pending·0 cites
- 4464US8951744B2Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancersAGENSYS INC·Filed 2012·Granted Feb 10, 2015·0 cites·19 claims
- 4564US7638270B2Nucleic acids and corresponding proteins entitled 254P1D6B useful in treatment and detection of cancerAGENSYS INC·Filed 2004·Granted Dec 29, 2009·1 cites·7 claims
- 4663US8524872B2Nucleic acids and corresponding proteins entitled 158P3D2 useful in treatment and detection of cancerRAITANO ARTHUR B·Filed 2012·Granted Sep 3, 2013·0 cites·5 claims
- 4763US2018258430A1Compositions and Methods for Inhibiting Gene Expression of Alpha-1 AntiTrypsinARROWHEAD PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 4863US2018179269A1Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancersAGENSYS INC·Filed 2017·Application pending·0 cites
- 4963US2025388900A1Compositions and Methods for Inhibition of Factor XII Gene ExpressionARROWHEAD PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 5063US2025325698A1Therapeutic applications of crispr type v systemsCARIBOU BIOSCIENCES INC·Filed 2023·Application pending·0 cites
Showing the top 50 of 66 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Steven B. Kanner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →